Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Gynecol Obstet Hum Reprod ; 48(4): 235-239, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29908951

RESUMEN

INTRODUCTION: The management of posterior deep endometriosis is not consensual. This is due to a great heterogeneity of data from the literature. Many series were small and overall, predictors of pregnancy were not all included and analyzed by multivariate analysis. We conducted this study to evaluate the factors associated with pregnancy during the first two in vitro fertilization (IVF) attempts in infertile women with posterior deep endometriosis. MATERIAL AND METHODS: 230 women were included in this retrospective observational study, between January 1st, 2007 and September 30th, 2013, at the University Hospital of Lille. A large set of variables were recorded and their association with the chance of pregnancy was analyzed by multivariate analysis (MVA), including patients' features, endometriosis items, surgery procedures and IVF data. RESULTS: After 2 IVF attempts, 48.7% of the 230 women achieved a pregnancy, including 39.1% of ongoing pregnancies. Logistic regression analysis retained five variables significantly associated to the chance of pregnancy: oocyte retrieval number (OR=0.468 (0.296-0.739) p=0.001), age (OR=0.888 (0.811-0.974) p=0.011), single embryo transfer number (OR=1.494 (1.036-2.153) p=0.031), presence of a recto-uterine nodule (OR=0.454 (0.235-0.877) p=0.019) and IVF technique (OR=0.509 (0.272-0.951) p=0.034). CONCLUSION: The presence of a recto uterine nodule is associated with a lower chance of pregnancy after IVF. It has to be checked by prospective studies whether the finding of a recto-uterine nodule whose pejorative effect has not been reported so far should encourage to perform surgery before IVF in patients with deep endometriosis.


Asunto(s)
Endometriosis/complicaciones , Fertilización In Vitro , Infertilidad Femenina/etiología , Infertilidad Femenina/terapia , Adulto , Endometriosis/patología , Endometriosis/cirugía , Femenino , Humanos , Imagen por Resonancia Magnética , Recuperación del Oocito , Enfermedades Peritoneales/complicaciones , Enfermedades Peritoneales/patología , Enfermedades Peritoneales/cirugía , Embarazo , Índice de Embarazo , Enfermedades del Recto/complicaciones , Enfermedades del Recto/patología , Enfermedades del Recto/cirugía , Estudios Retrospectivos , Transferencia de un Solo Embrión , Resultado del Tratamiento , Enfermedades Uterinas/complicaciones , Enfermedades Uterinas/patología , Enfermedades Uterinas/cirugía , Enfermedades Vaginales/complicaciones , Enfermedades Vaginales/patología , Enfermedades Vaginales/cirugía
2.
Ned Tijdschr Geneeskd ; 160: D666, 2017.
Artículo en Holandés | MEDLINE | ID: mdl-28074721

RESUMEN

BACKGROUND: Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of colorectal, gastric and breast carcinoma. Capecitabine has relatively mild side effects. Less known are its potential severe cardiotoxic effects. CASE DESCRIPTION: We report a case of a 61-year-old man recently diagnosed with rectal cancer. Six days after starting with capecitabine, he developed a cardiac arrest due to ventricular fibrillation (VF). Extensive additional diagnostics did not explain the cardiac arrest nor VF. Given the observed time relation between initiation of capecitabine administration and the occurrence of VF, combined with the absence of other causes for VF, we suspect that VF is a likely consequence of capecitabine-induced coronary vasospasm. CONCLUSION: Capecitabine-induced VF is a rare occurrence. With the increasing use of capecitabine for the treatment of various cancers, health professionals should be aware of these potential cardiotoxic side effects.


Asunto(s)
Antineoplásicos/efectos adversos , Capecitabina/efectos adversos , Fibrilación Ventricular/inducido químicamente , Vasoespasmo Coronario , Paro Cardíaco , Humanos , Masculino , Persona de Mediana Edad
3.
Gynecol Obstet Fertil ; 43(2): 109-16, 2015 Feb.
Artículo en Francés | MEDLINE | ID: mdl-25595945

RESUMEN

OBJECTIVE: Does surgery for deep infiltrating endometriosis (DIE) before in vitro fertilization (IVF) improve pregnancy and birth rate? PATIENTS AND METHODS: Cohort study of 177 consecutive patients with DIE related infertility and receiving IVF. Patients were divided into 3 groups according to surgical management decided during multidisciplinary team meeting. Group no surgery (NS) (n=65), group complete surgery (CS) with complete resection of all lesions (n=49) and group incomplete surgery (IS) with gestures improving ovaries accessibility for IVF and/or facilitating embryonic implantation (n=63). Pre-surgery clinical, MRI lesion locations, and history of IVF characteristics were analyzed with logistic regression. RESULTS: There was no significant difference in general and IVF characteristics and in the severity of endometriosis among the three groups (P=0.43). Overall pregnancy and birth rates after IVF were 45.8% and 33.3%, respectively and were not different among the 3 groups (P=0.59 and P=0.49). Four major complications during oocytes retrievals were observed in NS group, one in IS group and none in CS group. Presence of an inter-utero-rectal lesion at MRI decreased the rate of pregnancy (OR=0.49 [0.25, 0.97]). DISCUSSION AND CONCLUSIONS: Surgery for deep infiltrating endometriosis does not improve pregnancy and birth rates before IVF. This inter-utero-rectal extensive lesion might explain IVF failures by ovarian difficult access and difficulties in embryonic transfers. Further studies should explore the impact of surgical excision of inter-utero-rectal lesion on oocyte retrieval and embryonic transfer.


Asunto(s)
Tasa de Natalidad , Endometriosis/cirugía , Fertilización In Vitro , Índice de Embarazo , Adulto , Estudios de Cohortes , Endometriosis/patología , Femenino , Humanos , Infertilidad Femenina/terapia , Embarazo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA